BMY — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Bristol-Myers Squibb Company
Healthcare · $59.7
6.6
/10
Favorable Entry
↑ +1.1 today
Put-selling entry timing — not a quality rating.A high score reflects today's options setup, not a buy signal.
How this score works → Try the calculator ↓
Regime
Bullish
vs SMA200
SMA200 Distance
+0.4%
Above trend
Volatility
Low
Thin premiums
Momentum
Turning
was Decelerating
About Bristol-Myers Squibb Company
Pharma portfolio anchored by Eliquis (blood thinner) and Opdivo (immuno-oncology), both facing eventual patent cliffs, while Cobenfy (schizophrenia) and growth assets provide replacement optionality. Yields ~4.6%—among the highest in large-cap pharma. Very low beta (~0.27) but real idiosyncratic risk; pipeline data and patent litigation drive outsized moves.
Pharmaceuticals
Market Cap
$122.0B
P/E Ratio
13.2
Dividend
4.2%
Beta
0.18
52-Week Range Current: $59.7
$42.52 $68.64
Earnings
2026-10-29
21 days away

BMY — the structural read remains intact, but earnings in 21 days (2026-10-29) split the expiry choice in two. Pre-report and post-report contracts function as different setups.

Based on end-of-day market dataScored by ThetaLoop Research
BMY ranks #5 of 66 Healthcare tickers by put-selling score (617 total screened)

Position Size & Yield Calculator

Live model for BMY — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0 —
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
CVS CVS Health Corporation 8.3 RMD ResMed Inc. 8.2 JNJ Johnson & Johnson 7.9 INCY Incyte Corporation 7.2 REGN Regeneron Pharmaceuticals, Inc. 6.3 Browse all Healthcare tickers →
📌 Embed this score on your blog
The BMY X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/BMY" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/BMY">BMY X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Public Trade Ledger — All Recorded Closed Outcomes
Cash-Secured Put ledger ↗ · See a sample →